[HTML] mdpi.com

[HTML][HTML] Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

I Attili, A Passaro, P Pisapia, U Malapelle… - Current Oncology, 2022 - mdpi.com
Compound epidermal growth factor receptor (EGFR) mutations represent a heterogeneous
subgroup of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations …
被引用次数：42 相关文章
[HTML] nih.gov

[HTML][HTML] Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

I Attili, A Passaro, P Pisapia, U Malapelle… - Current …, 2022 - ncbi.nlm.nih.gov
Compound epidermal growth factor receptor (EGFR) mutations represent a heterogeneous
subgroup of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations …

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence.

I Attili, A Passaro, P Pisapia, U Malapelle… - Current …, 2022 - search.ebscohost.com
Compound epidermal growth factor receptor (EGFR) mutations represent a heterogeneous
subgroup of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations …
[PDF] semanticscholar.org

[PDF][PDF] Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

I Attili, A Passaro, P Pisapia, U Malapelle… - Curr …, 2022 - pdfs.semanticscholar.org
Compound epidermal growth factor receptor (EGFR) mutations represent a heterogeneous
subgroup of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations …

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

I Attili, A Passaro, P Pisapia… - Current oncology …, 2022 - pubmed.ncbi.nlm.nih.gov
Compound epidermal growth factor receptor (EGFR) mutations represent a heterogeneous
subgroup of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations …

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence.

I Attili, A Passaro, P Pisapia, U Malapelle… - Current Oncology …, 2022 - europepmc.org
Compound epidermal growth factor receptor (EGFR) mutations represent a heterogeneous
subgroup of non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations …

[引用][C] Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence

I Attili, A Passaro, P Pisapia, U Malapelle… - CURRENT …, 2022 - iris.unina.it
Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A
Systematic Review of Available Evidence IRIS IRIS Home Sfoglia Macrotipologie & …